Spark Investment Management LLC Cytom X Therapeutics, Inc. Transaction History

Spark Investment Management LLC

  • $17.4 Million
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$6.55 - $8.83 $98,905 - $133,333
-15,100 Closed
0 $0
Q2 2020

Aug 12, 2020
SELL
$7.4 - $14.64 $1.2 Million - $2.37 Million
-161,893 Reduced 91.47%
15,100 $125,000
Q1 2020

May 12, 2020
SELL
$3.61 - $8.6 $96,051 - $228,820
-26,607 Reduced 13.07%
176,993 $1.36 Million
Q4 2019

Feb 11, 2020
SELL
$5.17 - $8.91 $690,525 - $1.19 Million
-133,564 Reduced 39.61%
203,600 $1.69 Million
Q3 2019

Nov 12, 2019
SELL
$7.38 - $12.25 $707,129 - $1.17 Million
-95,817 Reduced 22.13%
337,164 $2.49 Million
Q1 2019

May 07, 2019
BUY
$9.5 - $19.16 $2.11 Million - $4.26 Million
222,381 Added 105.59%
432,981 $4.65 Million
Q4 2018

Feb 12, 2019
SELL
$12.69 - $18.61 $176,391 - $258,679
-13,900 Reduced 6.19%
210,600 $3.18 Million
Q3 2018

Nov 13, 2018
SELL
$18.04 - $26.41 $407,704 - $596,866
-22,600 Reduced 9.15%
224,500 $4.15 Million
Q2 2018

Aug 08, 2018
SELL
$21.38 - $29.68 $932,168 - $1.29 Million
-43,600 Reduced 15.0%
247,100 $5.65 Million
Q1 2018

May 10, 2018
BUY
$21.76 - $34.22 $1.17 Million - $1.84 Million
53,800 Added 22.71%
290,700 $8.27 Million
Q3 2017

Nov 13, 2017
BUY
$13.53 - $18.17 $3.21 Million - $4.3 Million
236,900
236,900 $4.3 Million

Others Institutions Holding CTMX

# of Institutions
71
Shares Held
50.7M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $69.9M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email